Gongwin Biopharm Holdings Co., Ltd. 6617.TWO Stock
Gongwin Biopharm Holdings Co., Ltd. Price Chart
Gongwin Biopharm Holdings Co., Ltd. 6617.TWO Financial and Trading Overview
| Gongwin Biopharm Holdings Co., Ltd. stock price | 182.5 TWD |
| Previous Close | 257 TWD |
| Open | 257 TWD |
| Bid | 249 TWD x 0 |
| Ask | 259.5 TWD x 0 |
| Day's Range | 248 - 259.5 TWD |
| 52 Week Range | 239 - 457 TWD |
| Volume | 101.36K TWD |
| Avg. Volume | 129.11K TWD |
| Market Cap | 29.35B TWD |
| Beta (5Y Monthly) | 0.783904 |
| PE Ratio (TTM) | N/A |
| EPS (TTM) | -0.81 TWD |
| Forward Dividend & Yield | N/A (N/A) |
| Ex-Dividend Date | N/A |
| 1y Target Est | N/A |
6617.TWO Valuation Measures
| Enterprise Value | 28.08B TWD |
| Trailing P/E | N/A |
| Forward P/E | N/A |
| PEG Ratio (5 yr expected) | N/A |
| Price/Sales (ttm) | 25675.06 |
| Price/Book (mrq) | 21.08556 |
| Enterprise Value/Revenue | 24567.973 |
| Enterprise Value/EBITDA | -111.345 |
Trading Information
Gongwin Biopharm Holdings Co., Ltd. Stock Price History
| Beta (5Y Monthly) | 0.783904 |
| 52-Week Change | -4.73% |
| S&P500 52-Week Change | 20.43% |
| 52 Week High | 457 TWD |
| 52 Week Low | 239 TWD |
| 50-Day Moving Average | 292.95 TWD |
| 200-Day Moving Average | 335.47 TWD |
6617.TWO Share Statistics
| Avg. Volume (3 month) | 129.11K TWD |
| Avg. Daily Volume (10-Days) | 149.36K TWD |
| Shares Outstanding | 113.09M |
| Float | N/A |
| Short Ratio | N/A |
| % Held by Insiders | 0% |
| % Held by Institutions | 0.041% |
| Shares Short | N/A |
| Short % of Float | N/A |
| Short % of Shares Outstanding | N/A |
Dividends & Splits
| Trailing Annual Dividend Rate | 0 |
| Trailing Annual Dividend Yield | 0% |
| 5 Year Average Dividend Yield | N/A |
| Payout Ratio | 0 |
| Last Split Factor |
Financial Highlights
Fiscal Year
| Fiscal Year Ends | December 31, 2022 |
| Most Recent Quarter (mrq) | December 31, 2022 |
| Next Fiscal Year End | December 31, 2023 |
Profitability
| Profit Margin | 0% |
| Operating Margin (ttm) | -22806.73% |
| Gross Margin | 93.26% |
| EBITDA Margin | 0% |
Management Effectiveness
| Return on Assets (ttm) | -11.66% |
| Return on Equity (ttm) | -24.75% |
Income Statement
| Revenue (ttm) | 1.14M TWD |
| Revenue Per Share (ttm) | 0.01 TWD |
| Quarterly Revenue Growth (yoy) | 0% |
| Gross Profit (ttm) | N/A |
| EBITDA | -252199008 TWD |
| Net Income Avi to Common (ttm) | -254188992 TWD |
| Diluted EPS (ttm) | -2.29 |
| Quarterly Earnings Growth (yoy) | N/A |
Balance Sheet
| Total Cash (mrq) | 1.11B TWD |
| Total Cash Per Share (mrq) | 9.78 TWD |
| Total Debt (mrq) | 141.74M TWD |
| Total Debt/Equity (mrq) | 10.32 TWD |
| Current Ratio (mrq) | 6.991 |
| Book Value Per Share (mrq) | 12.307 |
Cash Flow Statement
| Operating Cash Flow (ttm) | -232198000 TWD |
| Levered Free Cash Flow (ttm) | -255256256 TWD |
Profile of Gongwin Biopharm Holdings Co., Ltd.
| Country | Taiwan |
| State | N/A |
| City | Taipei |
| Address | No. 80, Jianguo North Road |
| ZIP | 104 |
| Phone | 886 2 2503 5282 |
| Website | https://www.gongwinbiopharm.com |
| Industry | Biotechnology |
| Sector(s) | Healthcare |
| Full Time Employees | N/A |
Gongwin Biopharm Holdings Co., Ltd., a clinical-stage biopharmaceutical company, develops anticancer drugs. It is developing PTS302, which has completed Phase III clinical trials for the treatment of lung cancer; PTS100, which is in Phase II clinical trials for the treatment of liver cancer; PTS-02 for the treatment of adenoid cystic carcinoma; and PTS500 for the treatment of malignant pleural effusion. The company was founded in 2014 and is based in Taipei, Taiwan.
Q&A For Gongwin Biopharm Holdings Co., Ltd. Stock
What is a current 6617.TWO stock price?
Gongwin Biopharm Holdings Co., Ltd. 6617.TWO stock price today per share is 182.5 TWD.
How to purchase Gongwin Biopharm Holdings Co., Ltd. stock?
You can buy 6617.TWO shares on the Taipei Exchange exchange. Contact your financial advisor to select a broker.
What is the ticker symbol for Gongwin Biopharm Holdings Co., Ltd.?
The stock symbol or ticker of Gongwin Biopharm Holdings Co., Ltd. is 6617.TWO.
Which industry does the Gongwin Biopharm Holdings Co., Ltd. company belong to?
The Gongwin Biopharm Holdings Co., Ltd. industry is Biotechnology.
How many shares does Gongwin Biopharm Holdings Co., Ltd. have in circulation?
The max supply of Gongwin Biopharm Holdings Co., Ltd. shares is 113.34M.
What is Gongwin Biopharm Holdings Co., Ltd. Price to Earnings Ratio (PE Ratio)?
Gongwin Biopharm Holdings Co., Ltd. PE Ratio is now.
What was Gongwin Biopharm Holdings Co., Ltd. earnings per share over the trailing 12 months (TTM)?
Gongwin Biopharm Holdings Co., Ltd. EPS is -0.81 TWD over the trailing 12 months.
Which sector does the Gongwin Biopharm Holdings Co., Ltd. company belong to?
The Gongwin Biopharm Holdings Co., Ltd. sector is Healthcare.